期刊文献+

胃癌组织中PIK3CA基因突变频率及热点突变模式

Investigation on mutation frequency of PIK3CA gene in gastric carcinoma and its hot spot mutation model
下载PDF
导出
摘要 目的:研究胃癌组织中PIK3CA基因突变频率及热点突变模式。方法:抽取患者的组织DNA,检测胃癌PIK3CA基因突变。结果:160例胃癌标本中有48例出现了胃癌PIK3CA基因突变(30.00%),其中第9外显子有27例突变(56.25%),第20外显子和第7外显子分别有14例和7例突变(29.17%、14.58%)。结论:PIK3CA基因突变频率30.00%且热点突变集中。 Objective:To explore the mutation frequency of PIK3CA gene in gastric carcinoma and its hot spot mutation model. Meth0ds:The mutation detection of DNA and PIK3CA gene was conducted, and the data was compared and analyzed. Results:There were 48 cases of mutation of PIK3CA gene presented among 160 cases, and the mutation rate was 30.00 % (48/160). The mutation occurred in 27 cases, and the mutation cluster region was the ninth exon, which accounted for 56.25 % of the total sample. In addition, there were 14 cases and 7 cases of mutation in the twentieth and seventh exon, respectively, accounting for 29.17 % and 14.58 %. Conclusions:The mutation frequency of PIK3CA gene in gastric cancer was up to 30.00 % and the hot spots of mutation were concentrated.
作者 邹伟 张欢
出处 《包头医学院学报》 CAS 2017年第3期91-92,共2页 Journal of Baotou Medical College
关键词 胃癌组织 PIK3CA基因 频率 模式 Gastric carcinoma PIK3 CA gene Frequency Model
  • 相关文献

参考文献4

二级参考文献18

  • 1陈琳玲,张佳,彭翠英,廖端芳,李弘剑,高汉林,李凯.DNA聚合酶高保真机理的新发现及其在SNP分析中的应用[J].遗传,2005,27(2):279-283. 被引量:8
  • 2<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:165
  • 3Volinia S, Hiles I, Ormondroyd E, et al. Molecular clo- ning, eDNA sequence, and chromosomal localization of the human phosphatidylinositol 3-kinas p110 alpha ( PIK3 CA) gene [ J ]. Genomics, 1994, 24:472-477.
  • 4White VL, Rickman C, Bond CE, et al. Oncogenic PIK3CA mutations in colorectal cancers and polyps [ J ]. Int J Canc- er, 2012, 131:813-820.
  • 5Dupont JJ, Laenkholm AV, Knoop A, et al. PIK3CA muta- tions may be discordant between primary and metastatic disease in breast cancer [ J ]. Clin cancer Res, 2011, 17 : 667-677.
  • 6Lee JW, Soung YH, Kim SY, et al. PIK3CA gene is fre- quently mutated in breast and hepatocellular carcinomas [ J]. Oncogene, 2005, 24 : 1477-1480.
  • 7Philp AJ, Campbell IG, Leet C, et al. The phosphatidyli- nositol 3'-kinase p85alpha gene is an oncogene in human o- varian and colon tumors [ J ]. Cancer Res, 2001, 61:7426-7429.
  • 8SamuelsY, Wang Z, Bardelli A, et al. High frequency of mutations of the PIK3CA gene in human cancers [ J ]. Sci- ence, 2004, 304:554-554.
  • 9Corso G, Velho S, Peredes J, et al. Oncogenic mutations in gastric cancer with mietosatellite instability [ J ]. Eur J Cancer, 2011,47:443-451.
  • 10Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastu- zumab in combination with chemotherapy versus chemother- apy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (TOGA) : a phase 3, open-label, randomised controlled trial[ J]. Lancet, 2010, 376: 687-697.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部